Novartis AG (NVS) – Bullish Recovery with Key Levels to WatchAnalysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong bas
Novartis AG
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.24 USD
14.06 B USD
54.81 B USD
1.91 B
About Novartis AG
Sector
Industry
CEO
Vasant Narasimhan
Website
Headquarters
Basel
Founded
1996
IPO date
May 7, 2001
Identifiers
3
ISIN US66987V1098
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
HHL.B
Harvest Healthcare Leaders Income ETF Trust Units B UnhedgedWeight
5.54%
Market value
72.27 M
USD
Explore more ETFs
